Carboxamide compounds and their use as calpain inhibitors IV
    93.
    发明授权
    Carboxamide compounds and their use as calpain inhibitors IV 有权
    羧甲酰胺化合物及其作为钙蛋白酶抑制剂的用途

    公开(公告)号:US08598211B2

    公开(公告)日:2013-12-03

    申请号:US12972679

    申请日:2010-12-20

    IPC分类号: A61K31/4439 C07D401/04

    摘要: The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity.The carboxamide compounds are compounds of the general formula I in which R1, R2, R3 R4, R5, m and n have the meanings mentioned in the claims and the description, the tautomers thereof, the hydrates thereof and the pharmaceutically suitable salts thereof. Of these compounds those are preferred wherein R1 is optionally substituted phenyl-C1-C2-alkyl or hetaryl-C1-C2-alkyl, R2 is optionally substituted aryl, hetaryl, aryl-C1-C6-alkyl, aryl-C2-C6-alkenyl or hetaryl-C1-C4-alkyl, R3 is C3-C4-alkyl, C1-C4-haloalkyl, C2-C4-alkenyl, C3-C6-cycloalkyl, C3-C6-cycloalkyl-C1-C2-alkyl, C3-C6-heterocycloalkyl-C1-C2-alkyl, phenyl-C1-C3-alkyl, pyridin-2-yl-C1-C3-alkyl or 1,3-benzoxazol-2-yl-methyl, R4 and R5 independently of one another are halogen, CF3, CHF2, CH2F, C1-C2-alkyl or C1-C2-alkoxy, and m and n independently of one another are 0 or 1.

    摘要翻译: 本发明涉及新的羧酰胺化合物及其用于制备药物的用途。 羧酰胺化合物是钙蛋白酶(钙依赖性半胱氨酸蛋白酶)的抑制剂。 因此,本发明还涉及这些羧酰胺化合物用于治疗与升高的钙蛋白酶活性相关的病症的用途。 羧酰胺化合物是通式I的化合物,其中R 1,R 2,R 3,R 4,R 5,m和n具有权利要求书和描述中所述的含义,其互变异构体,其水合物及其药学上合适的盐。 在这些化合物中,优选其中R 1为任选取代的苯基-C 1 -C 2 - 烷基或杂芳基-C 1 -C 2烷基,R 2为任选取代的芳基,杂芳基,芳基-C 1 -C 6 - 烷基,芳基-C 2 -C 6 - 烯基 或杂芳基-C 1 -C 4 - 烷基,R 3是C 3 -C 4 - 烷基,C 1 -C 4 - 卤代烷基,C 2 -C 4 - 烯基,C 3 -C 6 - 环烷基,C 3 -C 6 - 环烷基-C 1 -C 2烷基,C 3 -C 6 - 杂环烷基-C 1 -C 2 - 烷基,苯基-C 1 -C 3 - 烷基,吡啶-2-基-C 1 -C 3 - 烷基或1,3-苯并恶唑-2-基 - 甲基,R 4和R 5彼此独立地是卤素 ,CF 3,CHF 2,CH 2 F,C 1 -C 2 - 烷基或C 1 -C 2 - 烷氧基,m和n彼此独立地为0或1。

    LOW-MOLECULAR SERINE PROTEASES INHIBITORS COMPRISING POLYHYDROXY-ALKYL AND POLYHYDROXY-CYCLOALKYL RADICALS
    95.
    发明申请
    LOW-MOLECULAR SERINE PROTEASES INHIBITORS COMPRISING POLYHYDROXY-ALKYL AND POLYHYDROXY-CYCLOALKYL RADICALS 审中-公开
    包含聚羟基 - 烷基和聚羟基 - 环烷基基团的低分子丝氨酸蛋白酶抑制剂

    公开(公告)号:US20120190832A1

    公开(公告)日:2012-07-26

    申请号:US13277829

    申请日:2011-10-20

    IPC分类号: C07H15/26

    CPC分类号: A61K31/155 C07H7/00 C07H15/00

    摘要: The invention relates to novel amidines and quanidines, the production and use thereof and the use thereof as trypsine-type serine protease competitive inhibitors, especially thrombine and compliment proteases CIs and C1r. The invention also relates to pharmaceutical compositions which contain said compounds as active ingredients, in addition to the use of the compounds as thrombine inhibitors, anticoagulants, compliment inhibitors and anti-inflammatory agents. The novel compositions are characterised by the linkage of a serine protease inhibitor having amidine or guanidine functions with an alkyl radical having two or more hydroxyl functions, whereby said alkyl radical is derived from sugar derivates. Several sugar structural components or components derived from sugar can therefore be linked to each other. Said principle of linking sugar derivates enables oral active compounds to be obtained.

    摘要翻译: 本发明涉及新型脒和喹啉,其生产及其用途及其作为胰蛋白酶型丝氨酸蛋白酶竞争性抑制剂的用途,特别是血栓素和补体蛋白酶CI和C1r。 除了使用化合物作为血栓抑制剂,抗凝剂,补体抑制剂和抗炎剂之外,本发明还涉及含有所述化合物作为活性成分的药物组合物。 该新型组合物的特征在于具有脒或胍功能的丝氨酸蛋白酶抑制剂与具有两个或多个羟基官能团的烷基基团的连接,其中所述烷基衍生自糖衍生物。 因此,几种糖结构成分或来自糖的组分可以彼此连接。 所述连接糖衍生物的原理使得能够获得口服活性化合物。

    Organofunctional siloxane mixtures
    97.
    发明授权
    Organofunctional siloxane mixtures 有权
    有机官能硅氧烷混合物

    公开(公告)号:US07939616B2

    公开(公告)日:2011-05-10

    申请号:US10555984

    申请日:2004-03-18

    IPC分类号: C08G77/22

    CPC分类号: C08G77/26 C07F7/21 C08G77/04

    摘要: The present Invention relates to a mixture comprising catenary, branched and for cyclic siloxanes of the general formula (I) where x is 1, 2 or 3, the substituents R are (i) organofunctional groups selected from —CH2—SH, —CH2—S—(CO)—R′, —CH2—(O—C2H4)a—OH with a=1 to 10, —CH2(O—C2H4)b—OR′ with b=1 to 40, —(CH2)—NH2, —(CH2)—NHR′, —(CH2)—NR′2, —(CH2)—NH(CH2)2—NH2, —(CH2)—N[(CH2)2—NH2]2 and —(CH2)—NH(CH2)2—NH(CH2)2—NH2, In which R′ is a linear, branched or cyclic alkyl group having 1 to 18 carbon atoms or an aryl group having 6 to 12 carbon atoms, (ii) hydroxyl, methoxy, ethoxy, 2-methoxyethoxy, isopropoxy, n-propoxy, isobutoxy and for n-butoxy groupe, and (iii) where appropriate, alkyl, alkenyl, isoalkyl, cycloalkyl or fluorcalkyl groups having 1 to 18 carbon atoms or aryl groups having 6 to 12 carbon atoms, whit the proviso that not more than one organofunctional group (i) is attached per silicon atom, the quotient of the molar ratio of the moiety (ii) to silicon le from I to 2, and the degree of oligornerization for compounds of the general formula I is in the range from 2 to 50. The present invention also relates to a specific process for preparing said siloxane mixtures and also to their use.

    摘要翻译: 本发明涉及包含通式(I)的链状,支链和环状硅氧烷的混合物,其中x为1,2或3,取代基R为(i)选自-CH 2 -SH,-CH 2 - 具有a = 1-10的S-(CO)-R',-CH 2 - (O-C 2 H 4)a -OH,b = 1至40的-CH 2(O-C 2 H 4)b-OR', - (CH 2) NH 2, - (CH 2)-NHR', - (CH 2)-NR'2, - (CH 2)-NH(CH 2)2 -NH 2, - (CH 2)-N [(CH 2)2 -NH 2] 2和 - CH 2)-NH(CH 2)2 -NH(CH 2)2 -NH 2,其中R'是具有1至18个碳原子的直链,支链或环状烷基或具有6至12个碳原子的芳基,(ii) 羟基,甲氧基,乙氧基,2-甲氧基乙氧基,异丙氧基,正丙氧基,异丁氧基和正丁氧基,和(iii)适当的是具有1至18个碳原子的烷基,烯基,异烷基,环烷基或氟烷基或芳基 具有6至12个碳原子,条件是每个硅原子连接不超过一个有机官能团(i),其中th (ii)与硅的摩尔比为1至2,并且通式I化合物的低聚化程度在2至50的范围内。本发明还涉及制备所述 硅氧烷混合物以及它们的用途。